Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?

by Raúl Vozmediano-Chicharro, Blanca Madurga, Pedro Blasco
Published 2018-01-01

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain

by Carlos Crespo, Pedro Blasco, Marcelo Guigini, Jordi Galván